BICO Group Management

Management criteria checks 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Key information

Maria Forss

Chief executive officer

kr7.4m

Total compensation

CEO salary percentage	6.5%
CEO tenure	less than a year
CEO ownership	n/a
Management average tenure	1.2yrs
Board average tenure	3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Maria Forss's remuneration changed compared to BICO Group's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	kr7m	kr484k	-kr2b

Vergütung im Vergleich zum Markt: MariaDie Gesamtvergütung ($USD708.80K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD1.48M).

Entschädigung vs. Einkommen: Unzureichende Daten, um die Vergütung von Maria mit der Unternehmensleistung zu vergleichen.

CEO

Maria Forss (51 yo)

less than a year

Tenure

kr7,425,520

Compensation

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Maria Forss	President & CEO	less than a year	kr7.43m	no data
Erik Gatenholm	Co-Founder & Director	no data	kr5.19m	13.63% SEK 41.1m
Jacob Thordenberg	Group Chief Financial Officer	1.3yrs	no data	0.026% SEK 78.7k
Marius Balger	Chief Operating Officer	1.1yrs	no data	no data
Asa Hillsten	Senior VP & Head of Investor Relations	no data	no data	no data
Lotta Bus	SVP, General Counsel	4.3yrs	no data	0.0099% SEK 29.9k
Artur Aira	Head of Corporate Development and M&A	1.1yrs	kr150.00k	0.11% SEK 341.9k
Catharina Nordlund	Global Head of Human Resources	less than a year	no data	no data
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	no data	no data
Niclas Emanuelsson	Head of Global Operations	4.3yrs	no data	no data
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.3yrs	no data	no data
Erica Bell	Senior VP & Chief People Officer	no data	no data	no data

1.2yrs

Average Tenure

50.5yo

Average Age

Erfahrenes Management: CLLK.FDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Board Members

Name	Position	Tenure	Compensation	Ownership
Erik Gatenholm	Co-Founder & Director	8.3yrs	kr5.19m	13.63% SEK 41.1m
Rolf Classon	Independent Chairman of the Board	2yrs	kr650.00k	0.044% SEK 132.5k
Christian Wildmoser	Independent Director	4.3yrs	kr285.00k	0.45% SEK 1.4m
Robert Langer	Member of Scientific Advisory Board	3.4yrs	no data	no data
John Mackay	Independent Director	less than a year	kr250.00k	no data
Helena Skantorp	Independent Director	4.3yrs	kr350.00k	0.0057% SEK 17.1k
Ulrika Dellby	Independent Deputy Chairwoman	2yrs	kr510.00k	0.0085% SEK 25.6k
Bengt Sjoholm	Independent Director	8.3yrs	kr285.00k	0.49% SEK 1.5m
Susan Tousi	Independent Director	2.4yrs	kr250.00k	no data
Ali Khademhosseini	Member of Scientific Advisory Board	7.1yrs	no data	no data
Ido Amit	Member of Scientific Advisory Board	3.7yrs	no data	no data

3.7yrs

Average Tenure

63yo

Average Age

Erfahrener Vorstand: CLLK.FDie Vorstandsmitglieder gelten als erfahren (3.3 Jahre durchschnittliche Amtszeit).

BICO Group Management

Management criteria checks 2/4

Key information

Recent management updates

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) Announces Chief Executive Officer Changes

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group Announces Appointment of Nomination Committee 2023

Recent updates

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

BICO Group AB (Publ) Announces Board Appointments

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community

CELLINK to Help Develop 3D Bioprinted Personalised Scaffolds for Tissue Regeneration of Ankle Joint S as Part of the Triankle Project

Cellink AB (publ) to Report Second Half, 2020 Results on Oct 22, 2020

Cellink AB (Publ) Announces Leaving Board of Directors for an Operational Role as Business Area Manager for the Bioprinting Business Unit

Cellink AB (publ) (OM:CLNK B) completed the acquisition of SCIENION AG from NRW.Bank Venture Fonds, L.P., managed by NRW.Bank, Investment Arm and other shareholders.

Cellink AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 945.99632 million.

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age